By Brian Amaral ( April 6, 2017, 5:33 PM EDT) -- A federal judge in Boston said Thursday that he would allow Momenta and Sandoz to move again for dismissal in an antitrust dispute with Amphastar over a generic blood-clotting drug, and, depending on how that goes, eyed a tentative trial date two years from now....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.